Two New Treatment Advances For Coronary Artery Disease Patients
Sun, 11 Sep 2005 09:00 AM EST
... EMEA gives go-ahead for Coversyl® (perindopril) indication in stable CAD and marketing authorisation for Procoralan® (ivabradine), the first exclusive heart-rate reducing agent - Servier announced at the European Society of Cardiology (ESC) two major advances that will potentially help millions of patients with coronary artery disease (CAD)... click link for more info. ...
Related Topics
- Coronary Artery Disease
- Coronary Artery Diseases
- Coronary Disease
- Coronary Heart Disease
- Disease Prevention
- Coronary Artery Bypass Graft
- Coronary artery disease (from diabetes and high cholesterol)
- Heart Disease
- Atherosclerosis
- Heart Diseases--Prevention
- Angioplasty
- Risk Factors
- Coronary Artery
- Coronary Occlusion
- Coronary artery fistula
- Coronary artery spasm
- Anomalous left coronary artery
- Coronary Angioplasty
- Heart Diseases
- Acute Coronary Syndrome

Not Signed In -

